Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. OSG
OSG logo

OSG Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.810
Open
5.530
VWAP
5.59
Vol
1.30M
Mkt Cap
247.69M
Low
5.460
Amount
7.30M
EV/EBITDA(TTM)
--
Total Shares
44.95M
EV
708.83M
EV/OCF(TTM)
--
P/S(TTM)
1.04
Octave Specialty Group, Inc. is a global specialty insurance company that builds, buys, and scales niche insurance distribution and underwriting businesses. It provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. Its build-and-buy strategy is executed by its incubation division, Octave Ventures, and its acquisition division, Octave Partners. At Octave Ventures, it helps specialty underwriters to set up their own company, leveraging its resources. It offers funding, infrastructure, risk capital, and A+ rated paper as well as experienced guidance and support to underwriters looking to launch their own MGAs. Octave Partners identifies high-performing MGAs that would benefit from its partnership and add value to its expanding portfolio. To facilitate growth, it provides expertise, technology, distribution and capacity relationships, expansion and cross-company sales opportunities.
Show More

Events Timeline

(ET)
2026-02-23
16:10:00
Octave Specialty Group Reports Q4 Revenue of $66.9M
select

News

NASDAQ.COM
2.0
02-24NASDAQ.COM
Octave Specialty (OSG) Earnings Call Transcript
seekingalpha
9.5
02-23seekingalpha
Ambac Financial Group Q4 Earnings Beat Expectations
  • Earnings Beat: Ambac Financial Group reported a Q4 Non-GAAP EPS of -$0.02, surpassing expectations by $0.18, indicating resilience in challenging conditions that may bolster investor confidence.
  • Revenue Growth: The company achieved total revenue from continuing operations of $66.9 million, reflecting a 2.6% year-over-year increase, demonstrating its ability to maintain stable revenue growth in a competitive market environment, thereby strengthening its financial foundation.
  • Positive Market Reaction: The market reacted positively to the earnings report exceeding expectations, which could attract more investor attention, enhancing the liquidity and market recognition of Ambac's stock.
  • Optimistic Outlook: Despite the negative EPS, the revenue growth and favorable market response suggest that Ambac may implement effective measures to improve financial performance in the future, enhancing its competitiveness in the financial services industry.
seekingalpha
9.5
02-22seekingalpha
Ambac Financial Group to Announce Q4 Earnings on February 23
  • Earnings Announcement Date: Ambac Financial Group is set to release its Q4 earnings on February 23 after market close, with stakeholders keenly awaiting the results to assess the company's financial health.
  • Declining EPS Expectations: The consensus EPS estimate stands at -$0.20, reflecting a significant 66.7% year-over-year decline, indicating profitability pressures and market concerns regarding the company's future earnings potential.
  • Revenue Forecast: The consensus revenue estimate is $83.88 million, suggesting that despite challenges, Ambac is striving to maintain a certain revenue level, which could impact market confidence.
  • Historical Performance Review: Over the past two years, Ambac has beaten EPS estimates 50% of the time and revenue estimates 50% of the time, indicating a degree of volatility in the company's profitability metrics.
Businesswire
7.5
02-18Businesswire
Hammurabi Launches AI Platform to Transform Medical Stop Loss Insurance
  • AI Platform Launch: Hammurabi's newly unveiled AI platform utilizes neuro-semiotic models to significantly enhance underwriting efficiency in the medical stop loss insurance sector, reducing underwriting timelines from days to minutes in a $40 billion market while improving pricing accuracy and risk prediction capabilities.
  • Market Impact: The platform not only provides employers with self-funded health plans more precise health risk predictions but also generates competitive insurance proposals by processing unstructured documents, thereby enhancing market competitiveness and client attraction.
  • Industry Integration: Xchange Benefits has begun integrating Hammurabi's technology into its stop loss underwriting operations and has established a Hammurabi-branded underwriting division, reflecting industry leaders' recognition and confidence in this technology.
  • Strategic Investment: Xchange Benefits' strategic investment in Hammurabi's technology signifies a shift towards more efficient and accurate underwriting models in the insurance industry, indicating that AI applications will lead future industry transformations.
Newsfilter
7.5
02-18Newsfilter
Hammurabi Launches AI Platform to Transform Medical Stop Loss Insurance
  • Technological Innovation: Hammurabi's newly launched AI platform significantly enhances underwriting efficiency in medical stop loss insurance, reducing traditional underwriting timelines from days to minutes, which is expected to have a profound impact on the $40 billion medical stop loss market.
  • Risk Prediction Capability: The platform employs proprietary neuro-semiotic models to rapidly and accurately predict employer health risks, providing precise pricing and actionable insights for both employers and producers, thereby enhancing market competitiveness.
  • Industry Integration: Xchange Benefits has begun integrating Hammurabi's technology into its stop loss underwriting operations and has established a Hammurabi-branded underwriting division, demonstrating industry leaders' recognition and trust in this technology.
  • Strategic Investment: Xchange Benefits' strategic investment in Hammurabi's technology not only enhances its underwriting capabilities but also signifies a commitment to adapting to future shifts in insurance models, positioning the company to lead the revolution in medical stop loss insurance.
Newsfilter
5.0
02-10Newsfilter
Everspan Group Leadership Changes Announced
  • New President Appointment: Darwin Lucas has been appointed as President of Everspan Group, succeeding Steve Dresner, while continuing his role as Chief Underwriting and Reinsurance Officer since 2023, which positions him to drive the company's strategic execution and market expansion.
  • Strategic Execution Focus: Lucas will oversee Everspan's operations and strategic execution, leveraging his extensive experience in specialty insurance and reinsurance portfolio management to enhance the company's underwriting capabilities and market presence.
  • General Counsel Promotion: Nicole Crowley has been promoted to General Counsel from Assistant General Counsel, bringing over a decade of insurance law experience, which is expected to strengthen the company's legal compliance and risk management capabilities.
  • Leadership Transition: Dresner expressed gratitude for his time at Everspan and wished the company continued success, reflecting the stability and continuity within the organization during this leadership transition.
Wall Street analysts forecast OSG stock price to rise
2 Analyst Rating
Wall Street analysts forecast OSG stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
15.00
Averages
15.00
High
15.00
Current: 0.000
sliders
Low
15.00
Averages
15.00
High
15.00
No data

No data

Valuation Metrics

The current forward P/E ratio for Octave Specialty Group Inc (OSG.N) is -18.00, compared to its 5-year average forward P/E of -24.71. For a more detailed relative valuation and DCF analysis to assess Octave Specialty Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-24.71
Current PE
-18.00
Overvalued PE
-19.57
Undervalued PE
-29.86

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
68.08
Current EV/EBITDA
80.76
Overvalued EV/EBITDA
90.31
Undervalued EV/EBITDA
45.85

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.16
Current PS
0.99
Overvalued PS
1.23
Undervalued PS
1.10

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

RSI below 30 and MACD turning Bullish
Intellectia · 8 candidates
Rsi 14: 0 - 30Moving Average Relationship: PriceCrossAboveMA5
Ticker
Name
Market Cap$
top bottom
CORT logo
CORT
Corcept Therapeutics Inc
3.82B
ELME logo
ELME
Elme Communities
280.35M
OSG logo
OSG
Octave Specialty Group Inc
276.45M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
ATRA logo
ATRA
Atara Biotherapeutics Inc
33.17M
APLT logo
APLT
Applied Therapeutics Inc
14.63M

Whales Holding OSG

C
Caption Management, LLC
Holding
OSG
-1.25%
3M Return
T
Tontine Management, LLC
Holding
OSG
-1.76%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Octave Specialty Group Inc (OSG) stock price today?

The current price of OSG is 5.51 USD — it has decreased -0.36

What is Octave Specialty Group Inc (OSG)'s business?

Octave Specialty Group, Inc. is a global specialty insurance company that builds, buys, and scales niche insurance distribution and underwriting businesses. It provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. Its build-and-buy strategy is executed by its incubation division, Octave Ventures, and its acquisition division, Octave Partners. At Octave Ventures, it helps specialty underwriters to set up their own company, leveraging its resources. It offers funding, infrastructure, risk capital, and A+ rated paper as well as experienced guidance and support to underwriters looking to launch their own MGAs. Octave Partners identifies high-performing MGAs that would benefit from its partnership and add value to its expanding portfolio. To facilitate growth, it provides expertise, technology, distribution and capacity relationships, expansion and cross-company sales opportunities.

What is the price predicton of OSG Stock?

Wall Street analysts forecast OSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSG is15.00 USD with a low forecast of 15.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Octave Specialty Group Inc (OSG)'s revenue for the last quarter?

Octave Specialty Group Inc revenue for the last quarter amounts to 66.90M USD, increased 2.58

What is Octave Specialty Group Inc (OSG)'s earnings per share (EPS) for the last quarter?

Octave Specialty Group Inc. EPS for the last quarter amounts to -0.78 USD, decreased -93.19

How many employees does Octave Specialty Group Inc (OSG). have?

Octave Specialty Group Inc (OSG) has 275 emplpoyees as of March 11 2026.

What is Octave Specialty Group Inc (OSG) market cap?

Today OSG has the market capitalization of 247.69M USD.